Glutathione is the most abundant intracellular antioxidant in mammalian biology
and one of the most-discussed compounds in research-vendor catalogues, where it
sits in a category of its own — neither a true peptide-research compound like
BPC-157 nor a peptide therapeutic like the GLP-1 agonists. It is a defined small
molecule with decades of published clinical literature, much of it directly in
humans. This monograph lays out what glutathione actually is, what its biology
does and does not explain, what the research record looks like (it is unusually
large), and what to demand of a vendor before
evaluating any product.
Chemical identity and structure.
Glutathione (GSH) is a tripeptide composed of three amino acids — glutamate,
cysteine, and glycine — joined by an unusual gamma-peptide bond between the
glutamate side-chain carboxyl and the cysteine amine (rather than the usual
alpha-peptide bond seen in protein chemistry). The full sequence is
γ-L-glutamyl-L-cysteinyl-glycine; the molecular formula is C₁₀H₁₇N₃O₆S and the
molecular weight is 307.3 g/mol. The thiol (–SH) group on the cysteine residue
is the chemically active centre and is what makes glutathione a redox-cycling
molecule. The oxidised form, GSSG, is a disulfide-linked dimer of two GSH
molecules; the GSH:GSSG ratio inside a healthy cell is approximately 100:1,
and the ratio itself is a widely-used research marker of intracellular oxidative
state.
Mechanism of action.
Glutathione's research relevance derives from three biochemical roles. First,
it is the principal substrate for glutathione peroxidase, the enzyme that
detoxifies hydrogen peroxide and lipid peroxides — this is the antioxidant role
that most discussion focuses on. Second, it is a conjugation partner used by
glutathione S-transferases to render lipophilic xenobiotics water-soluble for
biliary or renal excretion — this is the Phase II detoxification role
extensively studied in toxicology. Third, it maintains the reduced state of
protein cysteines (the "redox buffer" function), which affects the activity of
hundreds of enzymes, transcription factors, and structural proteins. Unlike
many small molecules, glutathione is not a receptor agonist — its effects are
distributed across the metabolome rather than mediated through a single target.
Research applications and the evidence base.
Glutathione has, unusually for this corner of the market, a large body of
published human clinical research. Studies of glutathione have been published across hepatology
(non-alcoholic fatty liver, paracetamol toxicity), neurology (Parkinson's,
oxidative stress in neurodegeneration), pulmonology (cystic fibrosis,
chronic bronchitis), dermatology (skin-tone research and melanogenesis
modulation), and post-chemotherapy supportive-care contexts. PubMed and
EuropePMC together carry hundreds of glutathione clinical trials and
mechanistic papers. This makes glutathione one of the few compounds in
research-vendor catalogues with a genuinely substantial human evidence base —
even where individual study findings are mixed or modest, the literature exists
and can be read directly.
In the phase IIb double-blind, placebo-controlled trial by Mischley and colleagues (2017) in 45 individuals with Parkinson's disease, participants were randomized to receive intranasal placebo (saline), 100 mg GSH, or 200 mg GSH thrice daily for three months (PubMed); neither treatment group was superior to placebo.
Storage and handling.
Lyophilized glutathione is hygroscopic and oxidation-sensitive. Vials should be
kept refrigerated (2–8 °C) and protected from light. Avoid all
freeze-thaw cycles. The lyophilized powder should appear white to off-white;
any yellowing of the powder indicates oxidation and should
prompt re-checking the COA and discarding the batch.
Quality and COA considerations.
A meaningful COA for glutathione should report identity (mass spectrometry
confirming the expected 307.3 g/mol molecular weight), purity (HPLC, ≥99% is a
reasonable benchmark for a defined small molecule), and — critically — the
reduced/oxidised ratio or a direct measure of the active thiol content. A
sample of GSH that has partially oxidised to GSSG during manufacturing or
storage will pass an HPLC purity test (GSSG is a "related substance," not an
impurity) but will deliver less of the active reduced form per milligram than
the label implies. Endotoxin testing should also be reported if the vial is
being used in any model that touches injection or tissue contact.
*Research-use note: This monograph is an educational summary of the published
research literature for glutathione (GSH).
Glutathione has more human clinical research behind it than most compounds in
research-vendor catalogues, but none of the uses described
above is an approved therapy for the indications discussed. Nothing here is medical
advice or a usage recommendation.*
